Cardlytics, Inc.

CDLX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue$0$0$0$0
% Growth-10%3.6%11.8%
Cost of Goods Sold$0$0$0$0
Gross Profit$0$0$0$0
% Margin43.4%42.2%37.7%38.7%
R&D Expenses$0$0$0$0
G&A Expenses$0$0$0$0
SG&A Expenses$0$0$0$0
Sales & Mktg Exp.$0$0$0$0
Other Operating Expenses$0$0$0$0
Operating Expenses$0$0$1$0
Operating Income-$0-$0-$0-$0
% Margin-70.2%-43.9%-153.3%-45.9%
Other Income/Exp. Net$0$0-$0-$0
Pre-Tax Income-$0-$0-$0-$0
Tax Expense$0$0-$0-$0
Net Income-$0-$0-$0-$0
% Margin-68%-43.6%-155.8%-48.1%
EPS-3.91-3.69-13.92-3.99
% Growth-6%73.5%-248.9%
EPS Diluted-3.91-3.69-13.92-3.99
Weighted Avg Shares Out0000
Weighted Avg Shares Out Dil0000
Supplemental Information
Interest Income$0$0$0$0
Interest Expense$0$0$0$0
Depreciation & Amortization$0$0$0$0
EBITDA-$0-$0-$0-$0
% Margin-54.8%-32%-140.8%-33%
Cardlytics, Inc. (CDLX) Financial Statements & Key Stats | AlphaPilot